An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML

Edward Abadir; Pablo Silveira; Robin Gasiorowski; Murari Ramesh; Adelina Romano; Karieshma Kabani; Geoff Pietersz; Stephen Larsen; Georgina J. Clark

doi:10.1016/j.bbmt.2019.12.576

An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML

Edward Abadir, Pablo Silveira, Robin Gasiorowski, Murari Ramesh, Adelina Romano, Karieshma Kabani, Geoff Pietersz, Stephen Larsen, Georgina J. Clark

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	40
Pages (from-to)	S33
Number of pages	1
Journal	Biology of Blood and Marrow Transplantation
Volume	26
Issue number	3 Supplement
DOIs	https://doi.org/10.1016/j.bbmt.2019.12.576
Publication status	Published - Mar 2020
Externally published	Yes
Event	Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR - Orlando Duration: 19 Feb 2020 → 23 Feb 2020

Access to Document

10.1016/j.bbmt.2019.12.576

Cite this

Abadir, E., Silveira, P., Gasiorowski, R., Ramesh, M., Romano, A., Kabani, K., Pietersz, G., Larsen, S., & Clark, G. J. (2020). An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML. Biology of Blood and Marrow Transplantation, 26(3 Supplement), S33. Article 40. https://doi.org/10.1016/j.bbmt.2019.12.576

@article{dcae4c25bbe14731ac6fa6dffa7fcbcc,

title = "An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML",

author = "Edward Abadir and Pablo Silveira and Robin Gasiorowski and Murari Ramesh and Adelina Romano and Karieshma Kabani and Geoff Pietersz and Stephen Larsen and Clark, {Georgina J.}",

year = "2020",

month = mar,

doi = "10.1016/j.bbmt.2019.12.576",

language = "English",

volume = "26",

pages = "S33",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier",

number = "3 Supplement",

note = "Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR ; Conference date: 19-02-2020 Through 23-02-2020",

}

Abadir, E, Silveira, P, Gasiorowski, R, Ramesh, M, Romano, A, Kabani, K, Pietersz, G, Larsen, S & Clark, GJ 2020, 'An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML', Biology of Blood and Marrow Transplantation, vol. 26, no. 3 Supplement, 40, pp. S33. https://doi.org/10.1016/j.bbmt.2019.12.576

An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML. / Abadir, Edward; Silveira, Pablo; Gasiorowski, Robin et al.
In: Biology of Blood and Marrow Transplantation, Vol. 26, No. 3 Supplement, 40, 03.2020, p. S33.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML)

T2 - Transplantation and Cellular Therapy (TCT) Meetings of ASTCT and CIBMTR

AU - Abadir, Edward

AU - Silveira, Pablo

AU - Gasiorowski, Robin

AU - Ramesh, Murari

AU - Romano, Adelina

AU - Kabani, Karieshma

AU - Pietersz, Geoff

AU - Larsen, Stephen

AU - Clark, Georgina J.

PY - 2020/3

Y1 - 2020/3

U2 - 10.1016/j.bbmt.2019.12.576

DO - 10.1016/j.bbmt.2019.12.576

M3 - Meeting abstract

SN - 1083-8791

VL - 26

SP - S33

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 3 Supplement

M1 - 40

Y2 - 19 February 2020 through 23 February 2020

ER -

Abadir E, Silveira P, Gasiorowski R, Ramesh M, Romano A, Kabani K et al. An anti-CD300f antibody drug conjugate depletes hematopoietic stem cells and primary Acute Myeloid Leukemia (AML): facilitating a targeted conditioning regimen for allogeneic stem cell transplantation in AML. Biology of Blood and Marrow Transplantation. 2020 Mar;26(3 Supplement):S33. 40. doi: 10.1016/j.bbmt.2019.12.576